Evidence map›Paper›PMID 34297942›Full record

ArticleStem cell reports2021

Developing human pluripotent stem cell-based cerebral organoids with a controllable microglia ratio for modeling brain development and pathology.

Ranjie Xu, Andrew J Boreland, Xiaoxi Li, Caroline Erickson, Mengmeng Jin, Colm Atkins, Zhiping P Pang, Brian P Daniels, Peng Jiang

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed, 3 pooled it
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 3 syntheses or guidelines pooled it, 206 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Ranjie XuDepartment of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: ranjie.xu@rutgers.edu.
Andrew J BorelandDepartment of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ 08854, USA; Graduate Program in Molecular Biosciences, Rutgers University, Piscataway, NJ 08854, USA.
Xiaoxi LiDepartment of Immunology, Nanjing Medical University, Nanjing, China.
Caroline EricksonSummer Undergraduate Research Program in Neuroscience (NeuroSURP), Rutgers Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
Mengmeng JinDepartment of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ 08854, USA.
Colm AtkinsDepartment of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ 08854, USA.
Zhiping P PangDepartment of Neuroscience and Cell Biology and Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA.
Brian P DanielsDepartment of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ 08854, USA.
Peng JiangDepartment of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: peng.jiang@rutgers.edu.
Rutgers, The State University of New Jersey · USNanjing Medical University · CN

Funding

X-RAY STRUCTURE OF RIFM PROTEIN FROM THE BIOSYNTHESIS PATHWAY OF THE ANSAMYCIN AP41RR012408 · NCRR · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MARIUZZA, ROY A · 1998 to 2011
$32.2M
UMDNJ TRAINING GRANT IN BIOTECHNOLOGYT32GM008339 · NIGMS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI YARMUSH, MARTIN L · 1989 to 2019
$6.1M
Rutgers Biotechnology Training ProgramT32GM135141 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI ANN M. STOCK, Martin L Yarmush · 2020 to 2026
$3.5M
A Human iPSC-Based Chimeric Mouse Model of Alzheimers Disease in Down SyndromeR01AG073779 · NIA · RUTGERS, THE STATE UNIV OF N.J. · PI Peng Jiang · 2021 to 2026
$3.1M
Understanding Down Syndrome Brain Development Using Human iPSC-Based Mouse ChimerasR01NS122108 · NINDS · RUTGERS, THE STATE UNIV OF N.J. · PI Peng Jiang · 2021 to 2026
$2.1M
Novel Functions of OLIG2 in Regulating Human Interneuron Production in Health and DiseaseR01NS102382 · NINDS · RUTGERS, THE STATE UNIV OF N.J. · PI JIANG, PENG · 2018 to 2022
$1.6M
Developing an Astroglial Model for Down SyndromeR21HD091512 · NICHD · RUTGERS, THE STATE UNIV OF N.J. · PI JIANG, PENG · 2017 to 2018
$426k
Multimodal profiling of neurons in 3D human cortical organoids using patch-seqR21MH126420 · NIMH · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI LI, WEI VIVIAN, PANG, ZHIPING P. · 2021 to 2022
$426k
NCRR NIH HHS P41 RR012408NIA NIH HHS R01 AG073779NICHD NIH HHS R21 HD091512NIGMS NIH HHS T32 GM008339NIGMS NIH HHS T32 GM135141NIMH NIH HHS R21 MH126420NINDS NIH HHS R01 NS102382NINDS NIH HHS R01 NS122108
6 · The paper itself

Abstract

Microglia play critical roles in brain development, homeostasis, and disease. Microglia in animal models cannot accurately model human microglia due to notable transcriptomic and functional differences between human and other animal microglia. Incorporating human pluripotent stem cell (hPSC)-derived microglia into brain organoids provides unprecedented opportunities to study human microglia. However, an optimized method that integrates appropriate amounts of microglia into brain organoids at a proper time point, resembling in vivo brain development, is still lacking. Here, we report a new brain region-specific, microglia-containing organoid model by co-culturing hPSC-derived primitive neural progenitor cells and primitive macrophage progenitors. In the organoids, the number of human microglia can be controlled, and microglia exhibit phagocytic activity and synaptic pruning function. Furthermore, human microglia respond to Zika virus infection of the organoids. Our findings establish a new microglia-containing brain organoid model that will serve to study human microglial function in a variety of neurological disorders.

Indexed as

BrainCell DifferentiationCell LineCells, CulturedCoculture TechniquesGene Expression ProfilingHumansInduced Pluripotent Stem CellsMicrogliaModels, NeurologicalNeural Stem CellsOrganoidsPluripotent Stem CellsSynapsesZika VirusZika Virus Infectioncerebral organoidhuman iPSChuman pluripotent stem cellmicrogliasynaptic pruningZika virus

Identifiers

PMID34297942
PMCPMC8365109
OpenAlexW3186987912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.